{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:50:04Z","timestamp":1788925804345,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12905-018-0707-9","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T23:53:06Z","timestamp":1546905186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-1096","authenticated-orcid":false,"given":"Stacey","family":"Bryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeola","family":"Olaitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"issue":"6","key":"707_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/ijc.30821","volume":"141","author":"MT Faber","year":"2017","unstructured":"Faber MT, Sand FL, Albieri V, Norrild B, Kjaer SK, Verdoodt F. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Int J Cancer. 2017;141(6):1161\u20139.","journal-title":"Int J Cancer"},{"key":"707_CR2","unstructured":"Cancer Research UK, \u201cCancer research UK,\u201d [Online]. Available: \n                    https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/vaginal-cancer\n                    \n                  . Accessed 11 May 2018."},{"issue":"13","key":"707_CR3","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","volume":"51","author":"B Serrano","year":"2015","unstructured":"Serrano B, de Sanjose S, Tous S, Quiros B, Munoz N, Bosch X, Alemany L. Human Papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer. 2015;51(13):1732\u201341.","journal-title":"Eur J Cancer"},{"key":"707_CR4","unstructured":"National Cancer Institute, Surveillance Research Program, Cancer Statistics, \u201cSurveillance, Epidemiology, and End Results (SEER) program,\u201d 2006. [Online]. Available: \n                    www.seer.cancer.gov\n                    \n                  . Accessed 11 May 2018."},{"key":"707_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/his.12034","volume":"62","author":"M Pino Del","year":"2013","unstructured":"Del Pino M, Rodriguez-Carunchio L, Ordi J. Pathways of vulval intraepithelial neoplasia and squamous cell carcinoma. Histopathology. 2013;62:161\u201375.","journal-title":"Histopathology"},{"key":"707_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/jclinpath-2013-202117","volume":"67","author":"C Reyes","year":"2014","unstructured":"Reyes C, Cooper K. An update on vulvar intraepithelial neoplasia: terminology and a practical approach to diagnosis. J Clin Pathol. 2014;67:290\u20134.","journal-title":"J Clin Pathol"},{"key":"707_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0002-9378(16)33683-3","volume":"118","author":"DW Cramer","year":"1974","unstructured":"Cramer DW, Cutler SJ. Incidence and histopathology of malignancies of the female genital organs in the United States. Am J Obstet Gynecol. 1974;118:443\u201360.","journal-title":"Am J Obstet Gynecol"},{"key":"707_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1006\/gyno.2001.6401","volume":"83","author":"J Dodge","year":"2001","unstructured":"Dodge J, Eltabbakh GH, Mount SL, Walker RP, Morgan A. Clinical features and risk recurrence among patients with Vaginal Intraepithelial Neoplasia. Gynecol Oncol. 2001;83:363\u20139.","journal-title":"Gynecol Oncol"},{"key":"707_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejogrb.2017.09.020","volume":"218","author":"A Tranoulis","year":"2017","unstructured":"Tranoulis A, Laios A, Mitsopoulos V, Lutchman-Singh K, Thomakos N. Efficacy of 5% Imiquimod for the treatment of Vaginal Intraepithelial Neoplasia - a systematic review of the literature and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2017;218:129\u201336.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"707_CR10","doi-asserted-by":"crossref","unstructured":"Pepas L, Kaushik S, Nordin A, Bryant A, Lawrie TA. Medical interventions for high-grade vulval intraepithelial neoplasia, vol. 8: Cochrane Database Syst Rev; 2015. p. CD007924.","DOI":"10.1002\/14651858.CD007924.pub3"},{"key":"707_CR11","doi-asserted-by":"publisher","unstructured":"Lawrie TA, Nordin A, Chakrabarti M, Bryant A, Kaushik S, Pepas L. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia. Cochrane Database Syst Rev. 2016;(1). Art. No.: CD011837. \n                    https:\/\/doi.org\/10.1002\/14651858.CD011837.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD011837.pub2"},{"issue":"3","key":"707_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/LGT.0000000000000227","volume":"20","author":"MM Madeleine","year":"2016","unstructured":"Madeleine MM, Johnson LG, Doody DR, Tipton ER, Carter JJ, Galloway DA. Natural antibodies to human papillomavirus 16 and recurrence of vulvar high grade intraepithelial neoplasia (VIN3). J Low Genit Tract Dis. 2016;20(3):257\u201360.","journal-title":"J Low Genit Tract Dis"},{"key":"707_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3736201","volume":"2017","author":"APF Costa","year":"2017","unstructured":"Costa APF, Cobucci RNO, da Silva JM, da Costa Lima PH, Giraldo PC, Gon\u00e7alves AK. Safety of human papillomavirus 9-valent vaccine: A meta-analysis of randomized trials. J Immunol Res. 2017;2017:1\u20136.","journal-title":"J Immunol Res"},{"issue":"9","key":"707_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/INF.0000000000000773","volume":"34","author":"T Vesikari","year":"2015","unstructured":"Vesikari T, Brodszki N, van Damme P, Diez-Domingo J, Icardi G, Petersen L, Tran C, Thomas S, Luxembourg A, Baudin M. A randomized, double blind, phase 3 study of the immunogenicity and safety of a 9-valent human papillomavirus L1 virus-like particle vaccine (V503) versus Gardasil in 9-15-year-old girls. Pediatr Infect Dis J. 2015;34(9):992\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"707_CR15","first-page":"CD009069","volume":"5","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Simoens C, Martin-Hirsch PP. Prohylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors (review). Cochrane Database Syst Rev. 2018;5:CD009069.","journal-title":"Cochrane Database Syst Rev"},{"key":"707_CR16","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","volume":"25","author":"S-E Olsson","year":"2007","unstructured":"Olsson S-E, Villa LL, Costa RL, Petta CA, Andrade RP, Malm C, Iversen O-E, Hoye J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom A, Elfgren K, von Krogh G, Lehtin M. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV)types 6\/11\/16\/18 L1 virus-like (VLP) vaccine. Vaccine. 2007;25:4931\u20139.","journal-title":"Vaccine"},{"key":"707_CR17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00405-013-2755-y","volume":"271","author":"M Chirila","year":"2014","unstructured":"Chirila M, Bolboaca SD. Clinical efficiency of quadravalent HPV (types 6\/11\/16\/18) vaccine in patients with recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol. 2014;271:1135\u201342.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"10","key":"707_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1080\/14760584.2016.1176533","volume":"15","author":"P Vici","year":"2016","unstructured":"Vici P, Pizzuti L, Mariani L, Zampa G, Santini D, Di Lauro L, Gamucci T, Natoli C, Marchetti P, Barba M, Maugeri-Sacca M, Sergi D, Tomao F, Vizza E, Di Fillippo S, Paolini F, Curzio G, Corrado G, Michelotti A, Sanguineti G, Giordano A. Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies. Expert Review vaccines. 2016;15(10):1327\u201336.","journal-title":"Expert Review vaccines"},{"key":"707_CR19","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","volume":"361","author":"GG Kenter","year":"2009","unstructured":"Kenter GG, Welters MJ, Valentijn RP, Lowik MJ, Berends-van der Meer DM, Vloon AP, Essahsah F, Fathers LM, Offringa R, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren G. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med. 2009;361:1838\u201347.","journal-title":"N Engl J Med"},{"issue":"14","key":"707_CR20","first-page":"5205","volume":"9","author":"PJ Baldwin","year":"2003","unstructured":"Baldwin PJ, Van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Roberts JS, Latimer JA, Moseley RP, Coleman N, Stanley MA, Sterling JC. Vaccinia-expressed human papillomavirus 16 and 18 E6 and E7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res. 2003;9(14):5205\u201313.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"707_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/sj.bjc.6605611","volume":"102","author":"S Daayana","year":"2010","unstructured":"Daayana S, Elkford E, Winters U, Pawlita M, Roden R, Stern PL, Kitchenr HC. Phase 2 trial of Imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. Br J Cancer. 2010;102(7):1129\u201336.","journal-title":"Br J Cancer"},{"issue":"18","key":"707_CR22","first-page":"6032","volume":"63","author":"EJ Davidson","year":"2003","unstructured":"Davidson EJ, Boswell CM, Sehr P, Pawlita M, Tomlinson AE, McVey RJ, Dobson J, Roberts JS, Hickling J, Kitchener HC, Stern PL. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding HPV 16\/18 oncoproteins. Cancer Res. 2003;63(18):6032\u201341.","journal-title":"Cancer Res"},{"key":"707_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1525-1438.2006.00598.x","volume":"16","author":"AN Fiander","year":"2006","unstructured":"Fiander AN, Tristram AJ, Davidson EJ, Tomlinson AE, Man S, Baldwin PJ, Sterling JC, Kitchener HC. Prime-boost vaccination strategy in women with highgrade, noncervical anogenital intraepithelial neoplasia: Clinical results from a multicenter phase II trial. Int J Gynaecological Cancer. 2006;16:1075\u201381.","journal-title":"Int J Gynaecological Cancer"},{"issue":"9","key":"707_CR24","first-page":"3406","volume":"6","author":"L Muderspach","year":"2000","unstructured":"Muderspach L, Wilczynski S, Roman L, Bade L, Felix J, Small L, Kast WM, Fascio G, Marty V, Weber J. A phase 1 trial of human papillomavirus (HPV) peptide vaccine for women with high grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res. 2000;6(9):3406\u201316.","journal-title":"Clin Cancer Res"},{"key":"707_CR25","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00262-017-2006-y","volume":"66","author":"S Samuels","year":"2017","unstructured":"Samuels S, Marijne Heeren A, HJMAA Z, MJP W, van den Berg JH, Philips D, Kvistborg P, Ehsan I, SME S, Nuijen B, TNM S, van Beurden M, Jordanova ES, JBAG H, van der Burg SH, Kenter GG. HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia. Cancer Immunol Immunother. 2017;66:1163\u201373.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"707_CR26","doi-asserted-by":"publisher","first-page":"e90348","DOI":"10.1371\/journal.pone.0090348","volume":"9","author":"A Miltz","year":"2014","unstructured":"Miltz A, Price H, Shahmanesh M, Copas A, Gilson R. Systematic Review and Meta-Analysis of L1-VLP-Based Human Papillomavirus Vaccine Efficacy against Anogenital Pre-Cancer in Women with Evidence of Prior HPV Exposure. PLoS ONE. 2014;9(3):e90348.","journal-title":"PLoS ONE"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-018-0707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-018-0707-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-018-0707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T19:06:17Z","timestamp":1578337577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-018-0707-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1186\/s12905-018-0707-9","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"14 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"3"}}